Cognoptix Revitalizes, Appoints New Chief Executive Officer Dr. Susanne Wilke, PhD, Raises Oversubscribed $2.6m Series R

Cognoptix, a healthcare company developing the Sapphire II System, a breakthrough technology for early detection of Alzheimer’s disease (AD), announces the closing of an over-subscribed Series R financing round. Cognoptix has undergone a complete revitalization over the past year. Read more >>